Trending Market News
UPS CEO Carol Tome says the company's strategy to expand healthcare and prescription drug deliveries will help insulate it from economic uncertainty as an Iran conflict threatens global growth. The premium healthcare logistics business offers significantly higher profit margins than traditional e-commerce deliveries and is considered recession-resistant. UPS reported its first $3 billion healthcare revenue quarter, with healthcare now representing over 14% of consolidated revenue in Q1 2026.
- Healthcare shipment margins reach mid-to-high teen percentages versus very low single-digit percentages for e-commerce deliveries, driving profitability improvements
- UPS healthcare revenue hit $11.2 billion in 2025 (13% of total revenue) and exceeded 14% of revenue in Q1 2026, with the company gaining market share against dominant player DHL in the $80+ billion healthcare logistics market
- The company's multi-year restructuring under its 'better, not bigger' strategy is nearing completion, including reducing Amazon business from 13% to 8.8% of volume and cutting low-margin deliveries to focus on higher-profit specialized shipments
Apple's stock has been flat for six months, but options traders are pricing in significant volatility ahead of Thursday's earnings report. Implied volatility suggests a 3.5% post-earnings move, nearly double the 1.8% average from the last four quarterly reports, reflecting heightened uncertainty about the company's performance.
- Options activity shows mixed signals: call volumes outpace puts, but major trades include selling $290 and $300-strike calls for nearly $1 million premium and $240-$250 calls for over $3 million
- Recent earnings history favors bears, with Apple stock falling after five of its last six earnings reports and seven of the last ten
- At least one bullish trader paid above asking price for $330,000 worth of $320-strike calls expiring July 17, suggesting some optimism despite the stock's stagnation
Apple reports fiscal second-quarter earnings on Thursday, its first earnings call since announcing CEO Tim Cook will step down in September after 15 years, with hardware chief John Ternus taking over. Analysts expect 15% year-over-year revenue growth to $109.7 billion, driven primarily by a projected 20% jump in iPhone sales. Investors are focused on incoming CEO Ternus's vision for Apple's AI strategy, where the company has spent far less than Big Tech peers.
- Wall Street expects iPhone revenue of $56.7 billion, up 20% annually, fueled by strong iPhone 17 sales and new products including the $599 MacBook Neo laptop aimed at budget consumers
- Apple recently announced a partnership with Google to use its Gemini AI model for Siri, raising questions about the company's AI direction amid dramatically lower spending compared to rivals investing over half a trillion dollars this year
- Rising memory and storage costs from AI demand could pressure Apple's margins, though analysts believe the company has 'memory costs well under control' and has avoided significant device price hikes so far
Apple has accused India's Competition Commission of overstepping its authority by demanding financial information in an antitrust case involving the iPhone apps market, where Apple faces potential penalties. The company has challenged India's antitrust penalty calculation law in court and is resisting the CCI's attempts to proceed with a final hearing scheduled for May 21. This dispute marks an escalating confrontation between Apple and Indian regulators in a market where iPhones hold just 9% market share.
- Apple filed an urgent court petition on April 24 asking the Delhi High Court to intervene and halt the CCI's proceedings, arguing the commission is trying to 'usurp the Court's authority' by scheduling a May 21 final hearing
- The CCI investigation found Apple abused its dominant position in the apps market, and the regulator has been seeking Apple's financial information since 2024 to calculate potential penalties
- India represents a key growth market for Apple despite its relatively small 9% iPhone market share compared to Google's dominant Android platform
The Federal Communications Commission voted on April 30 to advance proposals significantly restricting Chinese technology operations in the U.S. The measures would bar Chinese labs from testing electronic devices like smartphones and cameras for U.S. use, and could prohibit three major Chinese telecom companies from operating data centers in the country while potentially banning U.S. carriers from connecting with those Chinese carriers.
- The FCC proposal would eliminate Chinese labs' ability to certify electronic devices including smartphones, cameras, and computers for the U.S. market
- A separate measure targets three major Chinese telecom companies, potentially barring their data center operations in the U.S.
- The proposals could further restrict U.S. telecom carriers from establishing connections with the targeted Chinese carriers
Gemini received U.S. CFTC approval to operate its own regulated derivatives clearinghouse, enabling in-house clearing and settlement of trades. This positions the crypto exchange to expand its prediction markets business and potentially launch perpetual futures trading. The move comes as Gemini's stock has fallen 90% from its September 2025 IPO debut amid broader crypto market weakness.
- The clearinghouse approval gives Gemini end-to-end control over its derivatives infrastructure, eliminating reliance on outside clearing services for prediction markets and future crypto derivatives products
- Gemini shares have dropped 90% since their September 2025 IPO (from ~$45 to $4.28), underperforming Bitcoin's 30% decline in the same period, while facing investor scrutiny over losses and strategic direction
- The company plans to diversify beyond crypto-only operations by adding equities trading and other asset classes to smooth revenue volatility tied to cyclical spot crypto trading volumes
Meta Platforms is planning to raise $20 billion to $25 billion through an investment-grade bond sale, according to Bloomberg News. This follows the company's record $30 billion bond offering last year and comes after Meta raised its 2026 capital expenditure forecast by $10 billion to a range of $125 billion to $145 billion. The move reflects Big Tech's shift toward debt financing after historically relying on cash flows.
- Meta previously completed its largest-ever bond offering of $30 billion in 2023, marking a strategic shift among tech giants toward debt financing
- The company increased its 2026 capital expenditure forecast to $125-145 billion, a $10 billion raise that may be driving the need for additional funding
- The bond sale represents part of a broader trend of Big Tech companies moving away from relying solely on strong cash flows to fund investments
Core inflation remained at 3.2% annually in March 2026, matching expectations, while GDP grew 2% in Q1. Rising oil prices from the Iran war drove overall inflation to 3.5% annually, creating new challenges for the Federal Reserve's monetary policy decisions.
- Core PCE (excluding food and energy) rose 0.3% monthly and 3.2% year-over-year, while headline inflation hit 3.5% annually due to surging oil and gas prices
- Q1 2026 GDP growth of 2% exceeded the previous quarter's 0.5% but fell short of the 2.2% estimate
- The Iran war's impact on oil markets has escalated consumer prices and complicated the Fed's inflation management strategy
President Trump claims his naval blockade will cause Iran's oil industry to 'explode' within days, forcing Tehran to negotiate a nuclear deal. However, energy experts say Iran has sufficient storage capacity to hold out for weeks or even months, allowing it to shut down production in an orderly manner without permanent damage. The blockade has already reduced Iranian oil loadings from 2.1 million barrels per day to 567,000 bpd.
- Iran has storage capacity for 26-76 days depending on assumptions, with at least 26 million barrels of onshore storage and 21 million barrels in floating storage available
- Experts dispute Trump's claim that oil infrastructure will 'explode,' stating Iran can ramp down oilfields in an orderly way to avoid permanent damage
- Iran has approximately 120 million barrels of oil loaded on tankers east of the blockade zone, equivalent to about two months of revenue if it can successfully sell and receive payment
Mastercard exceeded Wall Street's first-quarter profit expectations on April 30, driven by resilient consumer spending and strong transaction volumes despite economic uncertainty from the Iran war and U.S. tariffs. The company reported a 7% increase in gross dollar volume and 16% revenue growth to $8.4 billion, reflecting sustained spending particularly from wealthier households in a 'K-shaped' economy.
- Gross dollar volume increased 7% while net revenue climbed 16% to $8.4 billion in Q1, with adjusted profit per share of $3.73 beating analyst estimates of $3.68
- Cross-border transaction volume rose 13% despite Middle East airspace closures disrupting global flight corridors, indicating strong international spending resilience
- Spending patterns show economic bifurcation, with affluent households maintaining discretionary purchases in travel and entertainment while lower-income families reduce non-essential spending
The Japanese yen surged 2.1% against the dollar on Thursday after Japan's Finance Minister issued the strongest warning yet of potential currency intervention. The dollar fell to 156.985 yen, marking its largest one-day drop since August 2024, as Tokyo officials signaled 'decisive action' to support the weakening yen may be imminent.
- The dollar dropped 2.1% to 156.985 yen, on track for its biggest single-day decline since last August when it fell 2.25%
- Japan's Finance Minister stated the timing for 'decisive action' in currency markets was nearing, her strongest signal yet of possible intervention
- Investors currently hold their largest short position against the yen since July 2024, making the market vulnerable to sharp reversals from intervention or short covering
Altria, the maker of Marlboro cigarettes, exceeded Wall Street profit expectations in the first quarter despite declining cigarette volumes and increased competition in nicotine products. The company's strong performance was driven by higher pricing and effective cost controls that offset volume headwinds.
- Higher cigarette prices and cost management initiatives offset declining sales volumes
- Company faces intensifying competition in the broader nicotine products market
- Adjusted profit per share beat analyst expectations for the quarter
ConocoPhillips reported a decline in Q1 2026 net income to $2.18 billion and lowered its annual production forecast due to Middle East conflicts. Iranian attacks on Qatar's LNG export facility, where ConocoPhillips is a partner, damaged about one-sixth of Qatar's LNG capacity worth $20 billion annually, with repairs expected to take three to five years. The company expects 2026 production to fall to 2.295-2.325 million barrels of oil equivalent per day, down from 2.375 mmboed in 2025.
- Net income fell to $2.18 billion ($1.78 per share) in Q1 2026, reflecting lower profitability despite oil prices surging over 88% this year due to Middle East supply disruptions
- Damage to Qatar's LNG facility eliminated approximately one-sixth of the country's export capacity valued at $20 billion annually, with repairs projected to take 3-5 years
- 2026 production guidance reduced to 2.295-2.325 mmboed, down from 2.375 mmboed produced in 2025, excluding output from Qatar operations
Merck reported a first-quarter loss driven by a $3.62 per share charge related to its Cidara Therapeutics acquisition, despite a 5% increase in product sales to $16.3 billion. The revenue beat Wall Street estimates of $15.8 billion, fueled by strong performance from cancer drug Keytruda and respiratory treatment Winrevair. The company narrowed its full-year profit forecast range for 2026 to $5.04-$5.16 per share.
- Keytruda sales rose 12% to $8 billion, exceeding analyst estimates of $7.6 billion, including $128 million from a newer formulation of the world's top-selling prescription drug
- Winrevair sales surged 88% to $525 million, beating expectations of $479 million, while animal health sales jumped 13% to $1.8 billion
- Diabetes drug Januvia sales fell 28% to $574 million due to lower U.S. demand and generic competition, while HPV vaccine Gardasil declined 19% to $1.07 billion
Eli Lilly is set to report first-quarter earnings on Thursday, with Wall Street expecting $17.62 billion in revenue driven by strong demand for obesity drug Zepbound and diabetes drug Mounjaro. The report is highly anticipated as the company faces both growth opportunities from its newly launched GLP-1 pill Foundayo and pricing pressures from a Trump administration drug deal.
- Analysts expect Zepbound to generate $4.04 billion in sales and Mounjaro to bring in $7.26 billion, reflecting the company's dominant position in the GLP-1 market
- Foundayo, Lilly's newly approved GLP-1 pill for obesity, launched in Q2 and won't appear in this earnings report, but early prescription data suggest a 'modest' initial rollout compared to rival Novo Nordisk's Wegovy pill
- Lilly CEO expects global GLP-1 patient numbers to grow from 20 million at end of 2025 to 30 million by end of 2026, though the company faces pricing pressure from a Trump drug deal and lower cash-pay prices
Berkshire Hathaway is hosting its annual meeting where new CEO Greg Abel will lead discussions for the first time, marking a transition from Warren Buffett who remains executive chairman. The company reported $66.97 billion in net income for 2025, down 25% from 2024's record, with operating profit falling 6% to $44.49 billion. This leadership transition represents a pivotal moment for the conglomerate that Buffett has led since 1965.
- Greg Abel, who became CEO after Buffett's planned retirement, is a billionaire who sold his 1% stake in Berkshire Hathaway Energy for $870 million in 2022 and recently purchased $179 million of Berkshire stock
- Berkshire's 2025 results included $8.26 billion in writedowns for Kraft Heinz and Occidental Petroleum investments, though revenue remained stable at $371.44 billion
- Warren Buffett, worth $140.7 billion and ranked 12th worldwide, controls 30.2% of voting power with 13.7% stock ownership; his three children will inherit his remaining Berkshire holdings after his death
Cigna raised its annual adjusted profit forecast after beating first-quarter earnings estimates, driven by strong performance in its health services unit and lower-than-expected medical costs. The company has strategically exited Medicare Advantage and scaled back Obamacare offerings to focus on pharmacy benefits and employer-sponsored healthcare plans.
- Quarterly medical loss ratio came in at 79.8%, below the analyst estimate of 81.56%, reflecting better cost management and impact of divesting Medicare business to Health Care Service Corp
- Evernorth health services unit revenue rose nearly 9% to $58.44 billion in the quarter
- Adjusted earnings of $7.79 per share beat estimates, prompting the company to increase its 2026 full-year profit outlook
Chinese software company DSC Holdings received rare approval from China's securities regulator to list on Nasdaq, marking the first U.S. listing approval in four months and only the third in 12 months. The approval is significant because DSC is a 'red-chip' firm registered in the Cayman Islands, signaling that such offshore-registered companies can still access U.S. capital markets despite earlier fears of a blanket ban.
- DSC Holdings is incorporated in the Cayman Islands and provides operating systems for used car dealers in China, backed by investors including Ant Group
- The approval suggests China's securities regulator is taking a case-by-case approach rather than imposing a blanket ban on red-chip firms listing abroad
- Only about 50 Chinese companies are currently awaiting approval to list in the U.S., down from over 200 seeking Hong Kong listings, as geopolitical tensions and stricter rules since March 2023 have made U.S. listings harder
Bangladesh's state carrier Biman Bangladesh Airlines will sign a deal on Thursday to purchase 14 Boeing aircraft, reversing previous plans to buy from Airbus following a change in government. The decision is driven by the need to address a $6 billion trade imbalance with the United States and protect Bangladesh's export-driven economy from potential U.S. tariffs.
- The deal includes a mix of narrow-body and wide-body aircraft to modernize Biman's fleet, ending a prolonged Boeing-Airbus competition for the order
- Bangladesh shifted from Airbus to Boeing after the 2024 mass uprising toppled Prime Minister Sheikh Hasina's government, which had approved Airbus purchase plans
- The decision aims to ease trade pressure from a roughly $6 billion U.S. trade deficit and avoid tariff increases that could harm Bangladesh's garment export industry
India's securities regulator SEBI has approved a change of control at RBL Bank, marking a key milestone for Emirates NBD's proposed $3 billion acquisition of a 60% stake in the Indian lender. The deal, announced in October 2025, represents one of the largest cross-border transactions in India's financial sector and still requires additional regulatory approvals.
- SEBI granted approval on April 29, following India's central bank approval earlier in April that allows Emirates NBD to acquire up to 74% of RBL Bank
- Post-transaction, RBL Bank will be reclassified as a foreign bank subsidiary under Emirates NBD and governed by norms for wholly-owned foreign subsidiaries
- India's competition regulator cleared the $3 billion deal in January, with final closing subject to remaining regulatory conditions